It has been shown that the variant allele of rs784567, which is located in the promoter of the TRBP gene, was associated with neither a risk of bladder cancer (p = 0.07) [21] nor renal cell carcinoma [40] or oral premalignant lesions [41]. Here, TARBP2 is linked to renal cell carcinoma.